News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Berk Gregory
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Berk Gregory (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 278,058 shares
@ $0
Granted 50,000 options to buy
@ $6.33, valued at
$316.5k
|
|
| 02/14/2022 |
3
| Berk Gregory (Director) has filed a Form 3 on GT Biopharma, Inc. |
| 01/11/2017 |
4
| Berk Gregory (Chief Medical Officer) has filed a Form 4 on Verastem, Inc. |
| 11/01/2016 |
4
| Berk Gregory (CHIEF MEDICAL OFFICER) has filed a Form 4 on Verastem, Inc. |
| 04/19/2016 |
4
| Berk Gregory (Chief Medical Officer) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 370,000 options to buy
@ $1.51, valued at
$558.7k
|
|
| 04/19/2016 |
3
| Berk Gregory (Chief Medical Officer) has filed a Form 3 on Verastem, Inc. |
| 01/15/2014 |
4
| Berk Gregory (Chief Medical Officer) has filed a Form 4 on BIND Therapeutics, Inc|
Txns:
| Granted 4,967 options to buy
@ $2.78, valued at
$13.8k
Granted 4,967 options to buy
@ $2.78, valued at
$13.8k
Disposed/sold 4,967 options to buy
@ $2.78, valued at
$13.8k
Disposed/sold 4,453 options to buy
@ $2.52, valued at
$11.2k
Disposed/sold 64,189 options to buy
@ $2.52, valued at
$161.8k
|
|
| 03/16/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|